$ Value
$0
Shares
2,135
Price
$0
Filed
Feb 20
Insider
Name
KUPPUSAMY KARTHIK
Title
SVP, Clinical Solutions
CIK
0001955217
Roles
Transaction Details
Transaction Date
2026-02-18
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,049
Footnotes
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. | Represents an award of restricted stock units. | Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. | The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. | These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. | The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Filing Info
KUPPUSAMY KARTHIK's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | DGX | A | $1.3M |
| 2026-03-04 | DGX | ▼ | $538K |
| 2026-03-02 | DGX | F | $42K |
| 2026-02-18 | DGX | F | $53K |
| 2026-02-18 | DGX | F | $54K |
| 2026-02-18 | DGX | A | $0 |
| 2026-02-18 | DGX | A | $0 |
| 2026-01-28 | DGX | L | $3K |
| 2025-10-21 | DGX | A | $3K |
| 2025-08-13 | DGX | F | $22K |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $1.1M | 2026-03-05 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $2.0M | 2026-03-05 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $7.0M | 2026-03-05 |
|
Davis J. E.
CEO and President
|
— | $2.1M | 2026-03-04 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-03-04 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-03-04 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | $538K | 2026-03-04 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-03-04 |